Forecasts suggest that the comparable Uafida of the issuer in the fourth quarter reached 220 million dollars (mdd), bringing the annual result to 1,044 mdd, according to Elisa Vargas, an analyst at Grupo Financiero Ve Por Más. Vargas highlighted that the fourth quarter results for Alfa will be positive, driven by Sigma.
Vargas mentioned that a positive report is expected due to the results of Sigma, as well as solid volumes in Mexico and a price increase for the food company. In addition, she noted that results in the United States are expected to be in line with the previous quarter and that the divestment plan in Europe will continue to boost Alfa's results.
Regarding Alpek, a positive report is also expected, as the industry continues to show gradual improvement. According to Bloomberg consensus, a favorable outcome is anticipated, indicating that the industry is emerging from a low phase of the cycle.
Market analysts predict that during the fourth quarter of last year, Alfa and Alpek will present positive financial results, with Alfa supported by Sigma's performance and Alpek benefiting from the recovery of the industry.
Gerardo Cevallos, an analyst at Vector, mentioned that excluding Alpek due to its spin-off process, it is estimated that Alfa's revenues decreased by 1.3% in the fourth quarter of 2024, while comparable operating income would have fallen by 5.6%.
Regarding Sigma, sustained growth is anticipated due to strong demand and favorable costs, although the depreciation of the Mexican peso could impact results expressed in dollars.
It is projected that Sigma slightly exceeded its cash flow guidance for 2024 and gradual improvement is expected in 2025. For Alpek, sales are expected to reach 35,587 million pesos (mdp), an annual increase of 19.07%, an operating income of 3,233 mdp, an increase of 36.66% compared to the fourth quarter of 2023, and a net profit of 472 mdp.
